Indian Bank reported NII and PPoP growth of 31% and 10% YoY respectively on a merged basis, in line with expectations. Pro-forma Gross NPAs were marginally higher at 10.38% against 10.2% in the previous quarter, with pro forma PCR at 69%. The bank has made provisions of 20% against standstill NPAs.
OutlookValuing the bank at 0.7x Sep-22E P/ABV, implying a TP of Rs 130, we upgrade the stock to BUY from ACCUMULATE against a RoA of 0.6%/0.8% for FY22E/23E. The stock currently trades at 0.4x Sep22E PABV and has underperformed relative to the rest of PSU pack.
For all recommendations report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.